Browse
You are looking at 21 - 30 of 330 items for :
- Special Section x
- Refine by Content Type: All x
Physician assistants (PAs) are licensed clinicians, trained in the medical model, who practice medicine in every specialty, setting, and state. They are dedicated to expanding access to care and transforming health through patient-centered, team-based medical practice, and as such, nephrology is a perfect home. In 1997, a cohort of nephrology PAs, under the auspices of the American Academy of Physician Associates, created a specialty organization—American Academy of Nephrology PAs (AANPA)—for all facets of nephrology PAs (e.g., office, dialysis, transplant, and intensive care unit). In 2020, of <148,000 PAs in the United States working in 70 medical and surgical subspecialties, only
Physician assistants (PAs) have been colleague providers in health care since the late 1960s (
Patients with chronic kidney disease (CKD) and end stage kidney disease have complex medication regimens and multiple comorbidities and can take in excess of 12 medications daily (
Patients with chronic kidney disease (CKD) and end stage kidney disease have complex medication regimens and multiple comorbidities and can take in excess of 12 medications daily (
The number of patients requiring nephrology subspecialty care has grown tremendously. Unfortunately, while fellowship applicants have increased nearly 10% since 2019, nephrology has only had an increase of about 3% (
While physicians understand their own personal background, they may not understand the wide range of experiences of
The number of patients requiring nephrology subspecialty care has grown tremendously. Unfortunately, while fellowship applicants have increased nearly 10% since 2019, nephrology has only had an increase of about 3% (
While physicians understand their own personal background, they may not understand the wide range of experiences of
In the United States, approximately 40,000 new patients are added to the waitlist for kidney transplantation each year, yet in 2021, only 19,000 on the waitlist received deceased donor kidney transplants (
Focal segmental glomerulosclerosis (FSGS) recurrence post-transplantation represents one of the most challenging conditions causing kidney allograft failure. Despite intensive research over the past decades, many gaps remain in understanding its pathophysiology. Herein, we review several questions highlighting recent advancements and their potential use in clinical practice.
FSGS is not a specific disease entity but a histopathological “pattern of injury” seen on light microscopy that primarily targets podocytes. Multiple underlying etiologies that lead to podocyte loss have been identified, including systemic, genetic, and medication induced and those mediated by adaptive kidney responses (
The importance of genomic mismatch between donor and recipient in organ transplantation has been appreciated since Dr. Joseph E. Murray undertook the first successful kidney transplantation in 1954 (
In the 1990s and early 2000s, several
As featured in the July edition of
